Clinical trial TOUCH
Phase II open-label, multicenter, randomized trial of neoadjuvant palbociclib in combination with hormonal therapy and HER2 blockade versus paclitaxel in combination with HER2 blockade for elderly patients with hormone receptor positive/HER2 positive early breast cancer (IBCSG 55-17 / TOUCH)
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | IBCSG |
| EudraCT Identifier | 2017-005067-40 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03644186 |
| Inclusion criteria | ER+/HER2+. cT1-3. N0-1. >1 cm. Neoadjuvant. Age >65 years old |
| Last update |